Here are the Form 4 insider transactions from Bright Minds Biosciences Inc. (DRUG) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DRUG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DRUG filings page.
Cormorant Global Healthcare Master Fund, LP, an entity associated with Cormorant Asset Management and Bihua Chen, reported an open-market sale of 109,331 common shares of Bright Minds Biosciences Inc. at $89.50 per share.
After this transaction, the reporting structure shows 950,000 common shares indirectly held. The reporting persons, including Cormorant Asset Management and Bihua Chen, disclaim beneficial ownership of the reported shares except to the extent of their pecuniary interest.